Copyright Reports & Markets. All rights reserved.

Global Respiratory Diseases Diagnostic Testing Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Respiratory Diseases Diagnostic Testing Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Respiratory Diseases Diagnostic Testing Market Size Growth Rate by Product
      • 1.4.2 Imaging test
      • 1.4.3 Respiratory Measurement
      • 1.4.4 Blood gas test
      • 1.4.5 Other
    • 1.5 Market by End User
      • 1.5.1 Global Respiratory Diseases Diagnostic Testing Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Physician clinics
      • 1.5.4 Clinical laboratories
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Respiratory Diseases Diagnostic Testing Market Size
      • 2.1.1 Global Respiratory Diseases Diagnostic Testing Revenue 2014-2025
      • 2.1.2 Global Respiratory Diseases Diagnostic Testing Sales 2014-2025
    • 2.2 Respiratory Diseases Diagnostic Testing Growth Rate by Regions
      • 2.2.1 Global Respiratory Diseases Diagnostic Testing Sales by Regions
      • 2.2.2 Global Respiratory Diseases Diagnostic Testing Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Respiratory Diseases Diagnostic Testing Sales by Manufacturers
      • 3.1.1 Respiratory Diseases Diagnostic Testing Sales by Manufacturers
      • 3.1.2 Respiratory Diseases Diagnostic Testing Sales Market Share by Manufacturers
      • 3.1.3 Global Respiratory Diseases Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
    • 3.2 Respiratory Diseases Diagnostic Testing Revenue by Manufacturers
      • 3.2.1 Respiratory Diseases Diagnostic Testing Revenue by Manufacturers (2014-2019)
      • 3.2.2 Respiratory Diseases Diagnostic Testing Revenue Share by Manufacturers (2014-2019)
    • 3.3 Respiratory Diseases Diagnostic Testing Price by Manufacturers
    • 3.4 Respiratory Diseases Diagnostic Testing Manufacturing Base Distribution, Product Types
      • 3.4.1 Respiratory Diseases Diagnostic Testing Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Respiratory Diseases Diagnostic Testing Product Type
      • 3.4.3 Date of International Manufacturers Enter into Respiratory Diseases Diagnostic Testing Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Respiratory Diseases Diagnostic Testing Sales by Product
    • 4.2 Global Respiratory Diseases Diagnostic Testing Revenue by Product
    • 4.3 Respiratory Diseases Diagnostic Testing Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Respiratory Diseases Diagnostic Testing Breakdown Data by End User

    6 North America

    • 6.1 North America Respiratory Diseases Diagnostic Testing by Countries
      • 6.1.1 North America Respiratory Diseases Diagnostic Testing Sales by Countries
      • 6.1.2 North America Respiratory Diseases Diagnostic Testing Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Respiratory Diseases Diagnostic Testing by Product
    • 6.3 North America Respiratory Diseases Diagnostic Testing by End User

    7 Europe

    • 7.1 Europe Respiratory Diseases Diagnostic Testing by Countries
      • 7.1.1 Europe Respiratory Diseases Diagnostic Testing Sales by Countries
      • 7.1.2 Europe Respiratory Diseases Diagnostic Testing Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Respiratory Diseases Diagnostic Testing by Product
    • 7.3 Europe Respiratory Diseases Diagnostic Testing by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Respiratory Diseases Diagnostic Testing by Countries
      • 8.1.1 Asia Pacific Respiratory Diseases Diagnostic Testing Sales by Countries
      • 8.1.2 Asia Pacific Respiratory Diseases Diagnostic Testing Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Respiratory Diseases Diagnostic Testing by Product
    • 8.3 Asia Pacific Respiratory Diseases Diagnostic Testing by End User

    9 Central & South America

    • 9.1 Central & South America Respiratory Diseases Diagnostic Testing by Countries
      • 9.1.1 Central & South America Respiratory Diseases Diagnostic Testing Sales by Countries
      • 9.1.2 Central & South America Respiratory Diseases Diagnostic Testing Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Respiratory Diseases Diagnostic Testing by Product
    • 9.3 Central & South America Respiratory Diseases Diagnostic Testing by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Respiratory Diseases Diagnostic Testing by Countries
      • 10.1.1 Middle East and Africa Respiratory Diseases Diagnostic Testing Sales by Countries
      • 10.1.2 Middle East and Africa Respiratory Diseases Diagnostic Testing Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Respiratory Diseases Diagnostic Testing by Product
    • 10.3 Middle East and Africa Respiratory Diseases Diagnostic Testing by End User

    11 Company Profiles

    • 11.1 Philips Healthcare
      • 11.1.1 Philips Healthcare Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Philips Healthcare Respiratory Diseases Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Philips Healthcare Respiratory Diseases Diagnostic Testing Products Offered
      • 11.1.5 Philips Healthcare Recent Development
    • 11.2 BD
      • 11.2.1 BD Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 BD Respiratory Diseases Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 BD Respiratory Diseases Diagnostic Testing Products Offered
      • 11.2.5 BD Recent Development
    • 11.3 Abbott
      • 11.3.1 Abbott Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Abbott Respiratory Diseases Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Abbott Respiratory Diseases Diagnostic Testing Products Offered
      • 11.3.5 Abbott Recent Development
    • 11.4 Thermo Fisher Scientific
      • 11.4.1 Thermo Fisher Scientific Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Thermo Fisher Scientific Respiratory Diseases Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Thermo Fisher Scientific Respiratory Diseases Diagnostic Testing Products Offered
      • 11.4.5 Thermo Fisher Scientific Recent Development
    • 11.5 Roche
      • 11.5.1 Roche Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Roche Respiratory Diseases Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Roche Respiratory Diseases Diagnostic Testing Products Offered
      • 11.5.5 Roche Recent Development
    • 11.6 ResMed
      • 11.6.1 ResMed Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 ResMed Respiratory Diseases Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 ResMed Respiratory Diseases Diagnostic Testing Products Offered
      • 11.6.5 ResMed Recent Development
    • 11.7 Fischer & Paykel
      • 11.7.1 Fischer & Paykel Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Fischer & Paykel Respiratory Diseases Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Fischer & Paykel Respiratory Diseases Diagnostic Testing Products Offered
      • 11.7.5 Fischer & Paykel Recent Development
    • 11.8 Medtronic
      • 11.8.1 Medtronic Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Medtronic Respiratory Diseases Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Medtronic Respiratory Diseases Diagnostic Testing Products Offered
      • 11.8.5 Medtronic Recent Development
    • 11.9 MGC Diagnostics
      • 11.9.1 MGC Diagnostics Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 MGC Diagnostics Respiratory Diseases Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 MGC Diagnostics Respiratory Diseases Diagnostic Testing Products Offered
      • 11.9.5 MGC Diagnostics Recent Development

    12 Future Forecast

    • 12.1 Respiratory Diseases Diagnostic Testing Market Forecast by Regions
      • 12.1.1 Global Respiratory Diseases Diagnostic Testing Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Respiratory Diseases Diagnostic Testing Revenue Forecast by Regions 2019-2025
    • 12.2 Respiratory Diseases Diagnostic Testing Market Forecast by Product
      • 12.2.1 Global Respiratory Diseases Diagnostic Testing Sales Forecast by Product 2019-2025
      • 12.2.2 Global Respiratory Diseases Diagnostic Testing Revenue Forecast by Product 2019-2025
    • 12.3 Respiratory Diseases Diagnostic Testing Market Forecast by End User
    • 12.4 North America Respiratory Diseases Diagnostic Testing Forecast
    • 12.5 Europe Respiratory Diseases Diagnostic Testing Forecast
    • 12.6 Asia Pacific Respiratory Diseases Diagnostic Testing Forecast
    • 12.7 Central & South America Respiratory Diseases Diagnostic Testing Forecast
    • 12.8 Middle East and Africa Respiratory Diseases Diagnostic Testing Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Respiratory Diseases Diagnostic Testing Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Respiratory Diseases Diagnostic Testing market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Respiratory Diseases Diagnostic Testing market based on company, product type, end user and key regions.

      This report studies the global market size of Respiratory Diseases Diagnostic Testing in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Respiratory Diseases Diagnostic Testing in these regions.
      This research report categorizes the global Respiratory Diseases Diagnostic Testing market by top players/brands, region, type and end user. This report also studies the global Respiratory Diseases Diagnostic Testing market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Philips Healthcare
      BD
      Abbott 
      Thermo Fisher Scientific
      Roche
      ResMed
      Fischer & Paykel
      Medtronic
      MGC Diagnostics

      Market size by Product
      Imaging test
      Respiratory Measurement
      Blood gas test
      Other
      Market size by End User
      Hospitals
      Physician clinics
      Clinical laboratories
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Respiratory Diseases Diagnostic Testing market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Respiratory Diseases Diagnostic Testing market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Respiratory Diseases Diagnostic Testing companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Respiratory Diseases Diagnostic Testing submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Respiratory Diseases Diagnostic Testing are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Respiratory Diseases Diagnostic Testing market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now